Department of Medical Genetics, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Department of Pharmacology, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Eur J Med Genet. 2020 Dec;63(12):104100. doi: 10.1016/j.ejmg.2020.104100. Epub 2020 Nov 10.
Vitamin D plays an important role in calcium homeostasis and bone mineralization. Inefficient inactivation of vitamin D leads to a condition called idiopathic infantile hypercalcemia (IIH). In the last decade mutations in CYP24A1, the gene responsible for vitamin D inactivation, were described as the main molecular cause of IIH. In this study, we present a family with two daughters diagnosed with IIH due to two different mutations in CYP24A1 gene. Based on next-generation sequencing (NGS), the elder daughter was diagnosed as carrying the mutations CYP24A1: c.1186C > T; (p.Arg396Trp) and c.428_430del; (p.Glu143del). Within this context, we were able to presymptomatically diagnose her newborn sister using Sanger sequencing technique. Screening for CYP24A1 mutations in families with IIH history helps preventing disease manifestations in newborn siblings. Thus, NGS combined with Sanger sequencing validation opens up the perspective of preventive medicine with great impact on IIH management, where stopping vitamin D administration is enough to prevent disease manifestation, in most cases.
维生素 D 在钙稳态和骨矿化中发挥重要作用。维生素 D 失活效率低下会导致一种称为特发性婴儿高钙血症 (IIH) 的病症。在过去的十年中,CYP24A1 基因突变被描述为 IIH 的主要分子病因,CYP24A1 基因负责维生素 D 的失活。在本研究中,我们介绍了一个家系,该家系中有两个女儿因 CYP24A1 基因的两个不同突变而被诊断为 IIH。基于下一代测序 (NGS),大女儿被诊断为携带 CYP24A1 基因的突变:c.1186C>T; (p.Arg396Trp) 和 c.428_430del; (p.Glu143del)。在此背景下,我们能够使用 Sanger 测序技术对她的新生儿妹妹进行症状前诊断。对有 IIH 病史的家族进行 CYP24A1 突变筛查有助于预防新生儿兄弟姐妹的疾病表现。因此,NGS 结合 Sanger 测序验证为 IIH 管理带来了具有重大影响的预防医学前景,在大多数情况下,停止维生素 D 治疗足以预防疾病表现。